Ignite Creation Date:
2025-12-26 @ 2:42 PM
Ignite Modification Date:
2026-03-01 @ 7:58 AM
Study NCT ID:
NCT02465606
Status:
COMPLETED
Last Update Posted:
2020-01-27
First Post:
2015-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-30
Start Date Type:
ACTUAL
Primary Completion Date:
2016-05-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05-30
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-04
First Submit QC Date:
None
Study First Post Date:
2015-06-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-01-27
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-01-17
Last Update Post Date:
2020-01-27
Last Update Post Date Type:
ACTUAL